Study on the Protective Effect and Mechanism of the Rhizoma Drynariae-Epimedium Formula on Osteoarthritis in Rats

Dai, Zonghui

doi:https://doi.org/10.1155/2022/2869707

Contrast Media & Molecular Imaging

On this page

Abstract Introduction Materials and Methods Discussion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Special Issue

Developments in High Content Cellular Imaging Systems for Molecular Devices

View this Special Issue

Research Article | Open Access

Volume 2022 | Article ID 2869707 | https://doi.org/10.1155/2022/2869707

Study on the Protective Effect and Mechanism of the Rhizoma Drynariae-Epimedium Formula on Osteoarthritis in Rats

Zonghui Dai¹

Academic Editor: Mohammad Farukh Hashmi

Received04 May 2022

Revised15 May 2022

Accepted17 May 2022

Published29 May 2022

Abstract

Purpose. The aim of the study was to study the protective effect of the Rhizoma Drynariae-Epimedium formula on osteoarthritis in rats and to explore its mechanism. Methods. Fifty SD rats were randomly divided into 5 groups, namely, the control group, model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group, with 10 rats in each group. Knee arthritis models were established by injecting papain solution (10% papain + 0.03 mol/L L-cysteine mixture) into the knee joint cavity of SD rats on the 0th, 3^rd, and 6th days of the experiment, respectively. The model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group were given modeling treatment, while the control group was not given modeling treatment. The Rhizoma Drynariae group, Epimedium group, and the Rhizoma Drynariae-Epimedium group were, respectively, given corresponding solvent gavage treatment. Both the model group and the control group were given an equal volume of normal saline. Once a day, a total of 4 w were administered. The general conditions of the rats were observed and recorded, and the knee joint width and the knee joint swelling degree of the affected side were measured and compared. HE staining and Safranin O-fast green staining were used to compare the structural changes of cartilage. The concentrations of inflammatory factors IL-1β, IL-6, and TNF-α in the joint cavity lavage fluid were determined by using ELISA. The expression of key proteins of the MAPK signaling pathway (p38, p-p38, ERK, p-ERK, JNK, and p-JNK) in joint synovial tissue was determined by western blotting. Results. After modeling, except for the normal activities of the SD rats in the control group, the rest of the groups showed lack of energy and a slight limp in the knee joints. The SD rats in the model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group had local swelling of the knee joint, and the knee joint width was greater than those in the control group (). Compared with the model group, the knee joint swelling of SD rats in the Rhizoma Drynariae group, the Epimedium group, and the Rhizoma Drynariae-Epimedium group was significantly reduced. The knee joint swelling degree of SD rats in the Rhizoma Drynariae-Epimedium group was significantly lower than that in the Rhizoma Drynariae and Epimedium groups. HE staining and Safranin O-fast green staining showed that the cartilage structure of SD rats was severely damaged and eroded, and the subchondral bone mass was reduced. Compared with the model group, the damage of cartilage tissue in the Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group was less severe. In the Rhizoma Drynariae-Epimedium group, cartilage tissue structure damage and erosion were lighter than those of the Rhizoma Drynariae group and the Epimedium group. The concentrations of inflammatory factors IL-1β, IL-6, and TNF-α in the articular cavity lavage fluid of SD rats in the model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group were higher than those in the control group. Compared with the model group, the concentrations of IL-1β, IL-6, and TNF-α in the joint cavity lavage fluid of the Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group were significantly decreased. In the Rhizoma Drynariae-Epimedium group, IL-1β, IL-6, and TNF-α concentrations were lower than those of the Rhizoma Drynariae and Epimedium groups. Compared with the control group, the expression levels of p-p38, p-ERK, and p-JNK proteins in the model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group were significantly increased. The expression levels of p-ERK, p-p38 and p-JNK in the Drynariae group, Epimedium group, and Drynariae-Epimedium group were significantly lower than those in the model group. The expression levels of p-ERK, p-p38, and p-JNK in the Rhizoma Drynariae-Epimedium group were significantly lower than those in the Rhizoma Drynariae and Epimedium groups. Conclusion. The Rhizoma Drynariae-Epimedium formula can play a protective role in the process of osteoarthritis by inhibiting the phosphorylation levels of p38, ERK, and JNK-related proteins in the cartilage tissue MAPK signaling pathway, reducing the inflammatory response.

1. Introduction

Osteoarthritis (OA) is a common chronic, degenerative joint disease. It occurs in middle-aged and elderly people, and the incidence is proportional to age [1]. It is clinically characterized by destruction of articular cartilage, pain, and stiffness, which ultimately lead to immobility and the reduced quality of life for patients, thereby increasing the social and medical burden [2]. Artificial joint replacement is mainly suitable for advanced patients with severe symptoms, but there is still a lack of substantial progress in the treatment of early and midstage patients [3]. In-depth study of the pathogenesis of osteoarthritis has important clinical significance for improving the level of diagnosis and treatment of osteoarthritis. At present, the use of proprietary Chinese medicines to treat osteoarthritis has become a hot topic in the academic circles [4]. Rhizoma Drynariae, as a prescription in the treatment of osteoarthritis, has the effect of nourishing the liver and kidney, strengthening the muscles and bones [5]. Epimedium has the functions of invigorating the kidney and yang, strengthening the muscles and bones, and is a commonly used medicine in traditional Chinese medicine to prevent and treat osteoarthritis [6]. Although both Rhizoma Drynariae and Epimedium have certain benefits in the treatment of osteoporosis [7], the application value and mechanism of Rhizoma Drynariae-Epimedium in osteoarthritis are rarely reported. The purpose of this study was to establish the SD rat model of osteoarthritis, to study the protective effect of the Rhizoma Drynariae-Epimedium formula on rat osteoarthritis, and to explore its possible mechanism of action.

2. Materials and Methods

2.1. Experimental Materials

Papain (Article No.: P3250, Sigma), L-cysteine (Article No.: C0012-25, Beijing Solebo Technology Company), EDTA decalcification liquid (Article No.: B1056-100, Beijing Pleilai Co., LTD.), mouse interleukin-1β (IL-1β) ELISA Kit E-el-m0037c, Wuhan Ilerite Biological Co., LTD.), interleukin-6 (IL-6) (ELISA Kit Zc-37988, Shanghai Zhuocai Biological Company), tumor necrosis factor-α (TNF-α) (ELISA Kit Jl10484-48t, Shanghai Jianglai Biological Company), extracellular signal-regulated kinase (ERK) primary antibody (Article No.: AB242993, Abcam Company), p38 primary antibody (Article No.: Ab178867, Abcam), C-Jun N-terminal kinases (JNKs) primary antibody (Article No.: AB76125, Abcam), p-JNK primary antibody (Article No.: Ab219584, Abcam), p–p38 primary antibody (Article No.: AB240335, Abcam), p-ERK primary antibody (Article No.: AB214036, Abcam), GAPDH primary antibody (Article No.: Ab8245, Abcam Company), and sheep antirat second antibody were purchased from Wuhan Baishi Biological Company; western blotting kit (Wuhan Baishi Biological Company) and Bone Sububu and Herba medium were purchased from Anhui Zhengtang Traditional Chinese Medicine Drinks Co., LTD. Fifty male SD rats (SPF grade), weighing 250 ± 20 g, were purchased from experimental Animal Center of China Three Gorges University (License No. SCXK (E) 2017-0012).

2.2. Animals

Animal male BALB/c rats (10 weeks; 300–350 g) were provided by the Center for Animal Experiment of China Three Gorges University (Yichang, China). Mice were housed for at least 1 week in specific pathogen-free conditions, with a 12 h light/dark cycle prior to the experiment and unrestricted access to food and water. All experimental procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, Bethesda, MD, USA). The study protocol was also approved by the Animal Ethics Committee of Yangtze University (Jingzhou, China).

2.3. Establishment of Animal Models

The SD rats were randomly divided into 5 groups, namely, the control group, model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group, with 10 rats in each group. The modeling steps were as follows: intravenous injection of papain solution (10% papain + 0.03 mol/L L-cysteine mixture) into the knee joint cavity of SD rats to establish a knee arthritis model [8]. The rat model of knee arthritis was induced by injecting 0.2 mL of the modeling solution into the knee joint cavity of SD rats on the 0th, 3rd, and 6th days of the experiment, respectively. The model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group were given modeling treatment, while the control group was not given modeling treatment. After the last intra-articular injection of the knee joint, the Rhizoma Drynariae group, the Epimedium group, and the Rhizoma Drynariae-Epimedium group were, respectively, given the corresponding water decoction solution by gavage, and the gavage dose was 1.5 g/kg [9]. Both the model group and the control group were given an equal volume of normal saline. Once a day, a total of 4 w were administered. The general conditions of the rats were observed and recorded, and the rats were euthanized 4 weeks after modeling; the joint cavity lavage fluid, cartilage tissue, and synovial tissue of 5 groups were collected and stored in a −80°C refrigerator for testing.

2.4. Measurement of Joint Width and Joint Swelling in Rats

The right lower limb of the rat was stretched, the knee joint was exposed, and a vernier caliper was used to measure along the widest part of the knee joint, and the values were recorded before and 4 weeks after modeling. Calculation of the knee joint swelling degree: knee joint swelling degree = (joint width after 4 weeks − joint width before modeling)/joint width before modeling × 100%.

2.5. Histopathological Testing

The right knee joint was taken, and the extracted cartilage tissue was placed in an embedding box and fixed in formaldehyde for 24 h. After rinsing with clean water, decalcify 1 m with EDTA decalcification solution, and it is qualified if the needle can be inserted into the bone tissue specimen. Then, dehydration with gradient alcohol, clearing with xylene, dipping in wax, embedding, and sectioning were performed in sequence. Standard hematoxylin-eosin staining and Safranin O-fast green staining were performed, and histopathological changes were observed by light microscopy.

2.6. Detection of Inflammatory Factor Expression in the Joint Cavity Lavage Fluid Using ELISA

According to the instructions of the ELISA kit, the levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in the lavage fluids of the five groups were measured. The microplate reader is set to a wavelength of 450 nm, the OD value of each well is detected, and a standard curve is established to obtain the conversion formula between the concentration and the OD value, and the results are calculated based on this.

2.7. Determination of MAPK Signaling Pathway Protein Expression by Western Blot

The joint synovial tissue of the control group, model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group was placed on ice, and 150 μL of RIPA lysis solution containing protease inhibitor was added, and the synovial tissue was fully ground to a homogenate. The protein concentration was detected by the BCA method; then, a 5x buffer was added and denatured in a 100°C metal thermostatic incubator for 10 min. A 10% SDS-PAGE gel was prepared, and electrophoresis after protein loading was run. The constant pressure is first 80 V for 30 min and then transferred to 100 V for 2 h. When the bromophenol blue runs to the end, it is completed. Subsequently, the gel was cut and transferred into the PVDF membrane. After blocking with 5% nonfat milk for 1 hour at room temperature, incubate with the following specific antibodies for 16 hours at 4°C : ERK primary antibody (1 : 300), p38 primary antibody (1 : 300), JNK primary antibody (1 : 200), p-JNK primary antibody (1 : 200), p–p38 primary antibody (1 : 300), p-ERK primary antibody (1 : 300), and GAPDH primary antibody (1 : 500). After incubation, the PVDF membrane was rinsed with the TBST buffer for 10 min and rinsed 3 times. Then, a goat antimouse secondary antibody (1 : 800) was added and incubated at room temperature for 1 h, followed by rinsing with the TBST buffer for 10 min and rinsing 3 times. ECL solution was added to the PVDF membrane and exposed in the dark room, and the gray value of the target band was calculated with ImageJ software; target protein expression = gray value of target band/gray value of GAPDH band.

2.8. Statistical Analysis

Statistical analysis was performed using Prism GraphPad 8.0 software, and measurement data were expressed as the mean ± standard deviation (mean ± SD). One-way ANOVA was used for the comparison between multiple groups. On the basis of statistical significance, the LSD-T test was used for the comparison between the two groups. was considered to be statistically significant.

3. Result

3.1. Rhizoma Drynariae-Epimedium Decoction Improves Osteoarthritis Symptoms

General conditions of rats: before the experiment, SD rats in the 5 groups had a normal range of motion of knee joints, no local swelling, smooth fur, good sensitivity, normal mental state, and ability to eat and drink. SD rats did not die during the modeling process. After modeling, except for the normal activities of SD rats in the control group, the other groups showed different degrees of lack of energy and limping of the knee joint. SD rats in the model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group had local swelling of the knee joint, and the knee joint width was greater than that in the control group. Compared with the model group, the knee joint swelling of SD rats in the Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group was significantly decreased. The knee joint swelling degree of SD rats in the Rhizoma Drynariae-Epimedium group was significantly lower than that in the Rhizoma Drynariae and Epimedium groups (Figure 1).

(a)

(b)

3.2. Rhizoma Drynariae-Epimedium Decoction Inhibits Cartilage Tissue Damage

HE staining and Safranin O-fast green staining showed that after the injection of papain solution into the joint cavity, the cartilage structure of SD rats was severely damaged and eroded, and the subchondral bone mass was reduced. Compared with the model group, the damage of cartilage tissue in the Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group was less severe. The damage and erosion of the cartilage tissue structure in the Rhizoma Drynariae-Epimedium group were lighter than those in the Rhizoma Drynariae group and the Epimedium group (Figure 2).

3.3. Rhizoma Drynariae-Epimedium Decoction Reduces Joint Inflammation

ELISA results showed that the concentrations of inflammatory factors IL-1β, IL-6, and TNF-α in the joint cavity lavage fluid of SD rats in the model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group were higher than those in the control group. Compared with the model group, the concentrations of IL-1β, IL-6, and TNF-α in the joint cavity lavage fluid of the Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group were significantly decreased. The Rhizoma Drynariae-Epimedium group had lower concentrations of IL-1β, IL-6, and TNF-α than the Rhizoma Drynariae and Epimedium groups (Figure 3).

(a)

(b)

(c)

3.4. Effects of Rhizoma Drynariae-Epimedium Decoction on the MAPK Signaling Pathway

Western blotting experiments on joint synovial tissue of SD rats in 5 groups showed that compared with the control group, the expressions of p-p38, p-ERK, and p-JNK in the model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group were significantly increased. The expression levels of p-ERK, p-p38, and p-JNK in the Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group were significantly lower than those in the model group. The expression levels of p-ERK, p-p38, and p-JNK in the Rhizoma Drynariae-Epimedium group were significantly lower than those in the Rhizoma Drynariae and Epimedium groups (Figure 4).

(a)

(b)

(c)

(d)

4. Discussion

The theory of traditional Chinese medicine believes that “the kidney controls the bone and generates the marrow, which is the foundation of the innate,” and the strength of the bones is closely related to the filling of the kidney essence. Rhizoma Drynariae and Epimedium are commonly used prescriptions in the Department of Orthopedics and Traumatology of Traditional Chinese Medicine. Rhizoma Drynariae is the dry rhizome of Quercus quercus, a plant of the family Hydrangea, and its chemical constituents mainly include flavonoids, triterpenes, phenylpropanoids, and lignans [10]. The main active ingredient of Rhizoma Drynariae is total flavonoids. Total flavonoids can not only promote the proliferation of osteoblasts, reduce the activity of osteoclasts, increase bone density, inhibit bone resorption, and promote the healing of bone defects [11], but also have analgesic, lipid-regulating, and anti-inflammatory effects [12]. Epimedium is a traditional herbal medicine that has been used for centuries, and its main active ingredient is icariin, a prenylated flavonol glycoside [13]. Icariin can promote the formation of osteoblasts and activate the activity of osteoblasts, promote the transformation of bone marrow-derived mesenchymal stem cells into osteoblasts, promote the maturation of preosteoblasts, and inhibit the differentiation of primary osteoblasts into adipocytes [14]. In addition, icariin can inhibit bone resorption by inhibiting osteoclastogenesis, thereby inhibiting the biological activity of osteoclasts [15] and can also reduce bone loss by inhibiting inflammatory signaling pathways [16]. The two are often used as prescriptions and are often used clinically to treat rheumatism, fractures, bone defects, bone and joint diseases, osteoporosis, and gonadal dysfunction and have achieved good clinical results [17]. Wang et al. reported that the total flavonoids in Rhizoma Drynariae can induce changes in bone morphology, expression of the vascular endothelial growth factor and CD31, and promote bone healing and reconstruction [18]. Chen et al. reported that total flavonoids in Rhizoma Drynariae can promote the angiogenesis-osteogenesis coupling process in bone defect reconstruction by activating the notch pathway and ultimately promote the repair of defective bone [19]. Ding et al. reported that the total flavonoids in Rhizoma Drynariae can promote the proliferation of rat bone marrow mesenchymal stem cells and the differentiation of osteoblasts by upregulating the expressions of β-catenin and RunX2 and inhibiting and downregulating the expression of PPARG [20]. Yeung et al. reported that total flavonoids in Rhizoma Drynariae could inhibit matrix metalloproteinase 3 and TNF-α in SD rats, inhibit NF-kB signaling pathway, and then delay intervertebral disc degeneration [21]. It has also been reported in the literature that icariin can promote bone formation in SD rats with tibial fractures, and the expression of protein 2, vascular growth factor, Runt-related transcription factor 2, and alkaline phosphatase, thereby increasing the bone mineral density at the fracture site and promoting tibial healing [22].

Based on this, the author speculates that Rhizoma Drynariae-Epimedium may have a certain therapeutic effect on osteoarthritis. In this study, a papain-induced SD rat knee osteoarthritis model was established and SD rats were treated with decoction of Rhizoma Drynariae, Epimedium, and the Rhizoma Drynariae-Epimedium formula by gavage, respectively. All rats were observed for knee arthritis symptoms, pathological damage, inflammatory factor expression, and MAPK signaling pathway-related protein expression. After modeling, the knee joint swelling width and knee joint swelling degree were observed. It was found that SD rats in the model group, Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group had local swelling of the knee joint, and the degree of knee joint swelling was greater than that of the control group, indicating that the modeling of knee osteoarthritis was successful. HE staining and Safranin O-fast green staining showed that the damage and erosion of the cartilage structure of SD rats in the model group were severe, and the subchondral bone mass was reduced, while the damage and erosion of the cartilage tissue structure in the Rhizoma Drynariae-Epimedium group were lighter than those in the Rhizoma Drynariae and Epimedium groups. It is suggested that the Rhizoma Drynariae-Epimedium formula have a certain therapeutic effect on knee arthritis in SD rats, and the Rhizoma Drynariae-Epimedium group may play a synergistic therapeutic effect.

IL-1β, IL-6, and TNF-α are common cellular inflammatory factors, which are often used to reflect the inflammatory state of the body [23]. In this study, the expression of inflammatory factors in the SD rat knee lavage fluid was further determined. It was found that the concentrations of IL-1β, IL-6, and TNF-α in the joint cavity lavage fluid of the Rhizoma Drynariae group, Epimedium group, and Rhizoma Drynariae-Epimedium group were significantly lower than those of the control group; moreover, the Rhizoma Drynariae-Epimedium group was lower than the Rhizoma Drynariae group and the Epimedium group. These results suggest that the Rhizoma Drynariae-Epimedium formula can reduce the degree of inflammation of knee arthritis.

Inflammatory stimulation leads to the progressive loss of cartilage components, the destruction of cartilage structure and function, and the degradation of extracellular matrix, which are the main pathological changes of osteoarthritis [24]. Among them, the MAPK signaling pathway plays an important role in regulating the inflammatory response of bone and joint [25]. MAPKs are a class of serine/threonine protein kinases that are ubiquitous in eukaryotic cells. When the body is subjected to external stimuli such as trauma, inflammation, and bacterial infection, it will immediately initiate signal transduction, and it will be amplified step by step, affecting the transcription and expression of nuclear-related genes and finally causing a series of stress responses in cells [26]. The MAPK pathway has 4 main branch routes: ERK, JNK, p38, and ERK5 [27]. Among them, the JNK, p38, and ERK signaling pathways are all related to the inflammatory response. Under the stimulation of proinflammatory factors (TNF-α, IL-1, and IL-6 ) and stress stimulation (H₂O₂, heat shock, hypertonic and protein synthesis inhibitors, etc.), it can induce phosphorylation of JNK, p38, and ERK, stimulate JNK, p38, and ERK-related signaling pathways, and induce the activation of endogenous immune cells such as monocytes, endothelial cells, and neutrophils, thereby promoting the progression of inflammation [28]. In the inflammatory state, inflammatory factors such as IL-1β, IL-6, and TNF-α cause osteoclast differentiation and dysfunction through the RANK signaling pathway, resulting in excessive bone resorption, progressive loss of cartilage components, and destruction of the cartilage structure. This is the basic pathological feature of osteoporosis, arthritis, and other diseases. This study further investigates the changes in the JNK, p38, and ERK signaling pathways. It was found that the expressions of p-JNK, p-p38, and p-ERK in the Rhizoma Drynariae group, the Epimedium group, and the Rhizoma Drynariae-Epimedium group were all downregulated, and the JNK, p38, and ERK signaling pathways were inhibited; the reduction was more significant in the Rhizoma Drynariae-Epimedium group. These results suggest that the mechanism of mild inflammatory response and small knee injury in the Rhizoma Drynariae-Epimedium group may be related to inhibition of the JNK, p38, and ERK signaling pathways. Indeed, because this study is an animal experiment, the protective effect and mechanism of the Rhizoma Drynariae-Epimedium formula on knee cartilage cells have not been further elucidated at the cytological level, which deserves further study.

In summary, this study found that the Rhizoma Drynariae-Epimedium formula inhibits the release of inflammatory factors downstream of the pathway by inhibiting the phosphorylation levels of MAPK signaling pathway-related proteins p38, ERK, and JNK in cartilage tissue and exerts a protective role in the process of osteoarthritis. This will help further elucidate the mechanism of the Rhizoma Drynariae-Epimedium formula in the treatment of osteoarthritis and provide new ideas for drug research and development based on traditional Chinese medicine.

Data Availability

The data used to support the findings of this study are available from the author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

This research was supported by the Wuhan Municipal Health and Family Planning Commission (WX18D03).

References

M. Kloppenburg and F. Berenbaum, “Osteoarthritis year in review 2019: epidemiology and therapy,” Osteoarthritis and Cartilage, vol. 28, no. 3, pp. 242–248, 2020.
View at: Publisher Site | Google Scholar
H. Kan, P. K. Chan, P. Chan et al., “Non-surgical treatment of knee osteoarthritis,” Hong Kong Med J, vol. 25, no. 2, pp. 127–133, 2019.
View at: Publisher Site | Google Scholar
L. Chen and Y. Yu, “Exercise and osteoarthritis,” Physical Exercise for Human Health, vol. 1228, pp. 219–231, 2020.
View at: Publisher Site | Google Scholar
P. W. Tsai, Y. H. Lee, L. G. Chen, C. J. Lee, and C. C Wang, “In vitro and in vivo anti-osteoarthritis effects of 2,3,5,4′-tetrahydroxystilbene-2-O-β-d-Glucoside from polygonum multiflorum,” Molecules, vol. 23, no. 3, p. 571, 2018.
View at: Publisher Site | Google Scholar
R. C. Yang, C. C. Chang, J. M. Sheen, H. T. Wu, J. H. S. Pang, and S. T Huang, “Davallia bilabiata inhibits TNF-α-induced adhesion molecules and chemokines by suppressing IKK/NF-kappa B pathway in vascular endothelial cells,” The American Journal of Chinese Medicine, vol. 42, no. 6, pp. 1411–1429, 2014.
View at: Publisher Site | Google Scholar
D. Li, T. Yuan, X. Zhang et al., “Icariin: a potential promoting compound for cartilage tissue engineering,” Osteoarthritis Cartilage, vol. 20, no. 12, pp. 1647–56, 2012.
View at: Publisher Site | Google Scholar
F. Chen, Y. Chen, H. Li et al., “Study on the mechanism of treatment of osteoporosis with Gusubu-Epimedium based on network pharmacology and bioinformatics,” Chinese Journal of Osteoporosis, vol. 27, no. 5, pp. 727–734, 2021.
View at: Google Scholar
J. Liu, S. Liu, W. Pan, and Y. Li, “Wogonoside attenuates the articular cartilage injury and the infiltration of Th1/Th2-type cytokines in papain-induced osteoarthritis in rat model via inhibiting the NF-κB and ERK1/2 activation,” Immunopharmacol Immunotoxicol, vol. 43, no. 3, pp. 343–352, 2021.
View at: Publisher Site | Google Scholar
T. Van Gelder, J. Klupp, M. J. Barten, U. Christians, and R. E. Morris, “Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid,” Therapeutic Drug Monitoring, vol. 23, no. 2, pp. 119–28, 2001.
View at: Publisher Site | Google Scholar
W. Yao, H. Zhang, X. Jiang et al., “Effect of total flavonoids of rhizoma drynariae on tibial dyschondroplasia by regulating BMP-2 and Runx2 expression in chickens,” Frontiers in Pharmacology, vol. 9, p. 1251, 2018.
View at: Publisher Site | Google Scholar
L. G. Ming, K. M. Chen, and C. J. Xian, “Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling,” Journal of Cellular Physiology, vol. 228, no. 3, pp. 513–521, 2013.
View at: Publisher Site | Google Scholar
X. F. Li, H. Xu, Y. J. Zhao et al., “Icariin augments bone formation and reverses the phenotypes of osteoprotegerin-deficient mice through the activation of wnt/β-catenin-BMP signaling,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 652317, pp. 1–13, 2013.
View at: Publisher Site | Google Scholar
J. Huang, L. Yuan, X. Wang, T. L. Zhang, and K. Wang, “Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro,” Life Sciences, vol. 81, no. 10, pp. 832–840, 2007.
View at: Publisher Site | Google Scholar
T. P. Hsieh, S. Y. Sheu, J. S. Sun, and M. H. Chen, “Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE2 synthesis,” Phytomedicine, vol. 18, no. 2-3, pp. 176–185, 2011.
View at: Publisher Site | Google Scholar
Y. Si, Y. Yao, Y. Ma, Y. Guo, and H. Yin, “Effectiveness and safety of Guilu Erxian Glue (a traditional Chinese medicinal product) for the treatment of postmenopausal osteoporosis: A protocol for systematic review and meta-analysis,” Medicine (Baltimore), vol. 99, no. 29, Article ID e20773, 2020.
View at: Publisher Site | Google Scholar
M. Knippenberg, M. N. Helder, B. Z. Doulabi, R. A. Bank, P. I. Wuisman, and J. Klein-Nulend, “Differential effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on gene expression of collagen-modifying enzymes in human adipose tissue-derived mesenchymal stem cells,” Tissue Engineering Part A, vol. 15, no. 8, Article ID 19231972, pp. 2213–25, 2009.
View at: Publisher Site | Google Scholar
L. Li, P. Tang, Z. Zhou et al., “GIT1 regulates angiogenic factor secretion in bone marrow mesenchymal stem cells via NF-κB/Notch signalling to promote angiogenesis,” Cell Proliferation, vol. 52, no. 6, Article ID e12689, 2019.
View at: Publisher Site | Google Scholar
J. Wang, Li Jia, and G. Liu, “Effects of total flavonoids of Gusubuqi on multiplication and differentiation of rat bone marrow mesenchymal stem cells,” Journal of PLA Medical College, vol. 42, no. 2, p. 5, 2021.
View at: Google Scholar
C. Liu, H. Yang, F. Gao et al., “Resistin promotes intervertebral disc degeneration by upregulation of ADAMTS-5 through p38 MAPK signaling pathway,” Spine (Phila Pa 1976), vol. 41, no. 18, pp. 1414–1420, 2016.
View at: Publisher Site | Google Scholar
D. W. Zhang, Y. Cheng, N. L. Wang, J. C. Zhang, M. S. Yang, and X. S. Yao, “Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts,” Phytomedicine, vol. 15, no. 1-2, pp. 55–61, 2008.
View at: Publisher Site | Google Scholar
Y. T. Yeung, F. Aziz, A. Guerrero-Castilla, and S. Arguelles, “Signaling pathways in inflammation and anti-inflammatory therapies,” Current Pharmaceutical Design, vol. 24, no. 14, pp. 1449–1484, 2018.
View at: Publisher Site | Google Scholar
K. Wei, I. Korsunsky, J. L. Marshall et al., “Notch signalling drives synovial fibroblast identity and arthritis pathology,” Nature, vol. 582, no. 7811, pp. 259–264, 2020.
View at: Publisher Site | Google Scholar
G. Yang, C. C. Chang, Y. Yang et al., “Resveratrol alleviates rheumatoid arthritis via reducing ROS and inflammation, inhibiting MAPK signaling pathways, and suppressing angiogenesis,” Journal of Agricultural and Food Chemistry, vol. 66, no. 49, Article ID 12953, 2018.
View at: Publisher Site | Google Scholar
H. Du, X. Zhang, Y. Zeng et al., “A novel phytochemical, DIM, inhibits proliferation, migration, invasion and TNF-α induced inflammatory cytokine production of synovial fibroblasts from rheumatoid arthritis patients by targeting MAPK and AKT/mTOR signal pathway,” Frontiers in Immunology, vol. 10, p. 1620, 2019.
View at: Publisher Site | Google Scholar
Q. Fang, C. Zhou, and K. S. Nandakumar, “Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis,” Mediators of Inflammation, vol. 2020, Article ID 3830212, 2020.
View at: Publisher Site | Google Scholar
T. Behl, T. Upadhyay, S. Singh et al., “Polyphenols targeting MAPK mediated oxidative stress and inflammation in rheumatoid arthritis,” Molecules, vol. 26, no. 21, p. 6570, 2021.
View at: Publisher Site | Google Scholar
H. Liu, Y. Zhu, Y. Gao et al., “NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis,” Cell Death & Disease, vol. 11, no. 2, p. 129, 2020.
View at: Publisher Site | Google Scholar
B. Zhao, “TNF and bone remodeling,” Current Osteoporosis Reports, vol. 15, no. 3, pp. 126–134, 2017.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Zonghui Dai. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

329

Downloads

544

Citations